Amicus Therapeutics


Amicus Therapeutics Stock Quote
$14.60 $0.01 0.1%
Price as of August 12, 2020, 1:24 p.m. EDT View Interactive FOLD Charts

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

Interactive Chart

News & Analysis: Amicus Therapeutics

The Fool has written over 100 articles on Amicus Therapeutics.


Market Moves


Is Amicus Therapeutics a Buy?

The gene therapy stock is trading at its lowest level in over two years. It recently announced preliminary third-quarter 2019 operating results.